FDA Orange Book
Is there a generic for Livtencity?
Livtencity contains maribavir. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Livtencity (maribavir). The Orange Book shows its last listed patent expires October 11, 2043 and its last listed exclusivity ends November 23, 2028.
Run it in Rivvi
Map Livtencity and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Livtencity products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| tablet, oral | 200MG | Marketed (Rx) | None | 0 | None |
NDA 215596, held by TAKEDA PHARMACEUTICALS USA INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Livtencity patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 12447169 | October 27, 2031 | Method of use | U-4329 | 215596 |
| 12661368 | October 27, 2031 | Method of use | U-4572 | 215596 |
| 11684632 | January 4, 2032 | Method of use | U-3650 | 215596 |
| 12447170 | November 18, 2042 | Method of use | U-4328 | 215596 |
| 12213989 | November 18, 2042 | Method of use | U-4137 | 215596 |
| 12433907 | November 18, 2042 | Method of use | U-4289 | 215596 |
| 12527771 | October 11, 2043 | Drug substance, Drug product | None | 215596 |
| 12295940 | October 11, 2043 | Drug substance, Drug product | None | 215596 |
Livtencity exclusivity
| Code | Meaning | Expires | NDA |
|---|---|---|---|
| NCE | New chemical entity | November 23, 2026 | 215596 |
| ODE-388 | Orphan drug exclusivity | November 23, 2028 | 215596 |
Livtencity NDC codes
Questions
Is there a generic for Livtencity?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Livtencity (maribavir). The Orange Book shows its last listed patent expires October 11, 2043 and its last listed exclusivity ends November 23, 2028.
What is the generic name for Livtencity?
The active ingredient in Livtencity is maribavir, per the FDA Orange Book.
When does the Livtencity patent expire?
The last patent listed for Livtencity in the Orange Book expires October 11, 2043. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.